면역저하가 없는 환자에서 Alcaligenes xylosoxidans 에 의한 호흡기계 감염 2예

Two Cases of Pulmonary Infection due to A. xylosoxidans Infection in an Immunocompentent Patient

  • 이주현 (국민건강보험공단 일산병원 내과) ;
  • 남동혁 (국민건강보험공단 일산병원 내과) ;
  • 김도현 (국민건강보험공단 일산병원 내과) ;
  • 김선혜 (국민건강보험공단 일산병원 내과) ;
  • 김하나 (국민건강보험공단 일산병원 내과) ;
  • 한창훈 (국민건강보험공단 일산병원 내과) ;
  • 이선민 (국민건강보험공단 일산병원 내과) ;
  • 김정주 (국민건강보험공단 일산병원 내과)
  • Lee, Ju Hyun (Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) ;
  • Nam, Dong Hyuk (Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) ;
  • Kim, Do Hyun (Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) ;
  • Kim, Sun Hye (Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) ;
  • Kim, Ha Na (Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) ;
  • Han, Chang Hun (Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) ;
  • Lee, Sun Min (Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital) ;
  • Kim, Chong Ju (Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital)
  • 투고 : 2007.12.03
  • 심사 : 2008.01.18
  • 발행 : 2008.01.30

초록

A. xylosoxidans는 면역저하 상태에서 기회감염을 일으키며 호흡기 감염은 매우 드문 균으로 알려져 있다. 저자들은 최근 면역저하가 없는 환자에서 발생한 A. xylosoxidans에 의한 호흡기 감염증을 2예 경험하였기에 문헌 고찰과 함께 보고한다. 본 증례를 통해 정상면역을 가진 환자에서 A. xylosoxidans가 호흡기 감염의 원인일 수 있으며, 이와 같은 경우 세균학적 검사결과에 따른 적절한 치료가 필수적이라는 것을 경험하였다.

Alcaligenes xylosoxidans is a catalase and oxidase positive, motile, nonfermentative and gram-negative rod bacterium. A. xylosoxidans infection is a rare cause of pulmonary infection and little information concerning treatment is available. The majority of patients that develop A. xylosoxidans infection belong to a high-risk group due to an immunocompromised condition or due to pulmonary cystic fibrosis. We report two rare cases of immunocompentent patients that developed a pulmonary infection due to A. xylosoxidans. A 77-year-old man was admitted with a lung abscess. The patient denied having any prior medical illness. A culture of bronchial washing fluid showed the presence of A. xylosoxidans. Despite appropriate antibiotic treatment, the patient died from acute respiratory distress syndrome (ARDS). Another patient, a 61-year-old man without an underlying disease, was admitted with empyema. Under the condition of a closed thoracostomy, a high fever persisted and the empyema was also aggravated. A. xylosoxidans was detected from a culture of pleural fluid. Susceptible antibiotic treatment was provided and surgical intervention was performed. We report these cases with a review of the literature.

키워드

참고문헌

  1. Mandell WF, Garvey GJ, Neu HC. Achromobacter xylosoxidans bacteremia. Rev Infect Dis 1987;9:1001-5 https://doi.org/10.1093/clinids/9.5.1001
  2. Aisenberg G, Rolston KV, Safdar A. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 2004;101:2134-40 https://doi.org/10.1002/cncr.20604
  3. Gomez-Cerezo J, Suarez I, Rios JJ, Pena P, Garcia de Miguel MJ, de Jose M, et al. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis 2003;22:360-3 https://doi.org/10.1007/s10096-003-0925-3
  4. Kish MA, Buggy BP, Forbes BA. Bacteremia caused by Achromobacter species in an immunocompromised host. J Clin Microbiol 1984;19:947-8
  5. Knippschild M, Schmid EN, Uppenkamp M, Konig E, Meusers P, Brittinger G, et al. Infection by Alcaligenes xylosoxidans subsp. xylosoxidans in neutropenic patients. Oncology 1996;53:258-62 https://doi.org/10.1159/000227570
  6. Legrand C, Anaissie E. Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Clin Infect Dis 1992;14:479-84 https://doi.org/10.1093/clinids/14.2.479
  7. Mizunoe S, Yamasaki T, Hirai K, Yamagata E, Hiramatsu K, Yamakami Y, et al. Case report: subcutaneous abscess and thoracic empyema caused by Alcaligenes xylosoxidans. Kansenshogaku Zasshi 1998;72:631-4
  8. Shie SS, Huang CT, Leu HS. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan. J Microbiol Immunol Infect 2005;38:277-82
  9. Tsay RW, Lin LC, Chiou CS, Liao JC, Chen CH, Liu CE, et al. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates. J Microbiol Immunol Infect 2005;38:194-9
  10. Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE Jr. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis 2000;31:1183-7 https://doi.org/10.1086/317461
  11. Igra-Siegman Y, Chmel H, Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol 1980;11:141-5
  12. De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros 2007;6:75-8 https://doi.org/10.1016/j.jcf.2006.05.011
  13. Vay CA, Almuzara MN, Rodriguez CH, Pugliese ML, Lorenzo Barba F, Mattera JC, et al. 'In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp. Rev Argent Microbiol 2005;37:34-45
  14. Spear JB, Fuhrer J, Kirby BD. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature. J Clin Microbiol 1988;26:598-9
  15. Saiman L, Chen Y, Gabriel PS, Knirsch C. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes 3xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 2002;46:1105-7 https://doi.org/10.1128/AAC.46.4.1105-1107.2002